Targeting Batf2 for infectious diseases and cancer

This publication has 76 references indexed in Scilit:

• Exploring the potential of adjunct therapy in tuberculosis
  Trends in Pharmacological Sciences, 2015
• BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs
  Clinical Cancer Research, 2015
• Macrophage immunoregulatory pathways in tuberculosis
  Seminars in Immunology, 2014
• Metformin as adjunct antituberculosis therapy
  Science Translational Medicine, 2014
• A promoter-level mammalian expression atlas
  Nature, 2014
• Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
  The Journal of Infectious Diseases, 2013
• The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis
  PLOS ONE, 2012
• Adjunctive TNF Inhibition with Standard Treatment Enhances Bacterial Clearance in a Murine Model of Necrotic TB Granulomas
  PLOS ONE, 2012
• Doxycycline and HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases
  American Journal of Respiratory and Critical Care Medicine, 2012
• Repression of IL-2 Promoter Activity by the Novel Basic Leucine Zipper p21SNFT Protein
  The Journal of Immunology, 2000